echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Close to the New Year's pass! Drug prices are at a critical stage!

    Close to the New Year's pass! Drug prices are at a critical stage!

    • Last Update: 2021-01-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    the | As the King of the North enters the fourth quarter of 2020, diversified drug purchases are polarizing.
    provincial-level belt procurement is in full swing, the regular hanging network linkage action is also spread out.
    from a microcosmic point of view, the drug collection department, which was originally affiliated with the provincial health and planning committee system, has gradually completed the integration optimization, and drug procurement has entered the stage of rapid progress from the head of the steady word.
    At present, the mainstream focus of national drug procurement, mainly around the inter-provincial alliance collection negotiations and price reductions, this procurement method, not only for the future National Health Insurance Administration in the top-level planning of drug procurement, but also through two different types of procurement projects, to test the future drug procurement regional transactions "purity."
    the original words of a provincial drug collection leader, the National Health Insurance Administration to promote regional transactions should have four elements to consider: to have a cross-regional cooperation basis, to have strategic partner resources, to have organizational implementation capacity, to have the initiative to cooperate with the will! In addition, it is worth noting that at the level of drug procurement, the dynamic development of consistent evaluation is undoubtedly a happiness worry.
    In the past year, drug procurement in many provinces has often been passively patched for such varieties: the lowest average price of the three provinces in the country and the current list price of the province to take low value as a bargaining reference, there are procurement prices by medical institutions or procurement community and production enterprises directly negotiated to determine;
    the main current mainstream practice is that the local avoid the evaluation of varieties, mainly focusing on non-evaluation varieties of the volume of procurement and hanging network.
    At the same time, the determination of medical insurance payment standards, the cliff effect of patents for original research drugs, the adjustment of the base drug catalogue, the formulation of policies for the procurement of varieties through consistent evaluation (such as 4-7 and special procurement in various places) and other policies, the introduction of righteous prices and the promotion of implementation.
    are affected by the progress of the consistency evaluation, which is blocked and other work is blocked.
    It is worth noting that the standard of medical insurance payment, although the current national health insurance payment standards related policies have not been substantively introduced, but the relevant supporting policies are gradually from the "national health insurance catalog access", "national talks on the renewal of varieties" perspective, at the same time, the provinces are also speeding up the formulation of health insurance payment standards.
    To Fujian's sunshine procurement as an example, from the past two consecutive years of drug procurement to the current provincial movement, medical insurance payment reference price and the highest sales price of drugs, procurement price is forming a relatively consistent price ecological closed loop, both machine linkage, while continuing to roll.
    Septh a glimpse of the Panthers, from this point of view, in the current transition period, the provincial medical institutions in the balance of the interests of the interests of the background, is fully prying the health insurance payment standard leverage, the enthusiasm for volume exchange will not be reduced in the slightest.
    At present, after standardized adjustment, the national centralized procurement and local collection, will be optimized in the local way of development, but the volume of price exchange, price reduction control fee of the overall thinking will not be adjusted, production and operation enterprises to learn to adapt.
    After three batches of four rounds of national belt procurement, the state has not only the initial impression of the belt with budget procurement, for the use of large pharmaceutical enterprises a large number of products, the provinces will be the national joint harvest as a blue book group procurement, the use of small and some exclusive, patented drugs will be negotiated or negotiated.
    the same time, filing procurement, matchmaking transactions, RFQ procurement will present the normal steps.
    hospitals will have the voice and decision-making power to purchase, especially in the context of clinical pathways and pay-per-disease, resource utilization control will be more stringent, will pay attention to the exact efficacy of the hospital will actively participate in cost control.
    Under the new situation, centralized procurement of medicines will still take into account the nature of the country and the local distinction, the high probability will continue to inherit the general principle of classified procurement, the division of full competition, direct network, bargaining negotiations, pilot alliance procurement, fixed-point production and other means, to carry out volume procurement.
    it is worth mentioning that future procurement catalogues will become more and more difficult to enter.
    the implementation of centralized drug procurement catalog standardized adjustment has been the general trend.
    At the same time, it should be noted that under the gradual promotion of the retention policy of collection balance, in the context of the gradual start of clinical substitution of products in the same therapeutic field requested by the relevant parties, under the requirements of clinical pathways and pay-per-disease, the control of the utilization of medical resources will be more stringent, and medical institutions will further take the initiative to reduce costs on the basis of various operational assessments.
    Through three batches of four-wheeled national procurement, the national belt procurement fully reflects from the "for use and pick" to "should be exhausted" thinking, the future evaluation of enterprises to reach 3 or more are likely to be included in the national belt procurement.
    , while other sporadic "stones" and "stones" (generics that have not been evaluated or are largely evaluated as hopeless), are carried out by provincial organizations with volume procurement or regional alliance organizations.
    Through the above analysis, it can basically be judged that the relevant national parties to the next step of centralized procurement has a general direction, it is basically certain that the relevant parties still hope to inter-provincial joint mainly, on the one hand, the provincial platform resources are relatively mature, on the other hand, the area covered can be rapidly expanded.
    The author had speculated in the early stage that the national belt procurement is establishing a demonstration effect, the provincial level and the state are forming a mutually promoting pattern of recruitment, if part of the city and then innovative individual carry volume procurement, may have a certain impact on the overall pharmaceutical and consumables belt procurement pattern.
    from the present point of view, go all out to do a good job in the fourth batch of national mining, and then refer to the national blue book and then continue to do a good job at the provincial and local level city with the volume of procurement, will still unswervingly go on.
    , that is, the national and local have been pilot-oriented, grasping large and small, will be large fish net, play a demonstration role.
    time is right, all the big fish and shrimp will be net, so that cross-no dead end multi-dimensional price adjustment, so as to truly form a quality-first, cost-first pharmaceutical market new pattern.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.